Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma

Published:2014-12 Issue: Volume:127 Page:106-111
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Ichikawa Tomotsugu,Kurozumi Kazuhiko,Michiue Hiroyuki,Ishida Joji,Maeda Yoshinobu,Kondo Eisei,Kawasaki Akihiro,Date Isao

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference35 articles.

1. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis;Olson;Cancer,2002

2. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan;Makino;Surg Neurol,2006

3. Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD);Glass;J Neurooncol,1996

4. Treatment for primary CNS lymphoma: the next step;Abrey;J Clin Oncol,2000

5. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10;DeAngelis;J Clin Oncol,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Cognitive Function, Anxiety, and Depression in Patients With Newly Diagnosed Primary Central Nervous System Lymphoma;Biological Research For Nursing;2023-08-04

2. Applying prednisone after radioactive iodine is helpful to reduce gastrointestinal reactions for papillary thyroid carcinoma patients;2023-03-29

3. A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell Therapy;NMC Case Report Journal;2022-12-31

4. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma;Internal Medicine;2022

5. Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review;Cancers;2021-08-24